Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 4/2012

01-04-2012 | Case Report

Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis

Authors: Soo-Kyung Cho, Il Hwan Oh, Chan Kum Park, Sang-Cheol Bae, Yoon-Kyoung Sung

Published in: Rheumatology International | Issue 4/2012

Login to get access

Abstract

TNF inhibitors are being used in a rapidly expanding number of rheumatoid arthritis (RA) patients due to their effectiveness and acceptable safety profiles. To date, concerns regarding the adverse effects of TNF inhibitors have focused on infections, hematologic malignancies, and demyelinating disorders. Recently, the development of autoantibodies and other autoimmunity has been increasingly reported. Here, we describe a 36-year-old RA patient in whom organizing pneumonia and systemic lupus erythematosus were detected during etanercept treatment.
Literature
1.
Moreland LW, Weinblatt ME, Keystone EC et al (2006) Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience. J Rheumatol 33:854–861PubMed
2.
Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50:1740–1751PubMedCrossRef
3.
Mohan N, Edwards ET, Cupps TR et al (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44:2862–2869PubMedCrossRef
4.
Ramos-Casals M, Brito-Zeron P et al (2008) Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol 22:847–861PubMedCrossRef
5.
Caramaschi P, Biasi D, Colombatti M et al (2006) Anti-TNF alpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol Int 26:209–214PubMedCrossRef
6.
Moreland LW, Schiff MH, Baumgartner SW et al (1999) Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 130:478–486PubMed
7.
Schlesinger C, Koss MN (2005) The organizing pneumonias: an update and review. Curr Opin Pulm Med 11:422–430PubMedCrossRef
8.
9.
Mori S, Cho I, Koga Y, Sugimoto M (2008) A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature. Mod Rheumatol 18:60–66PubMedCrossRef
10.
Kajiya T, Kuroda A, Hokonohara D, Tei C (2006) Radiographic appearance of bronchiolitis obliterans organizing pneumonia (BOOP) developing during Bucillamine treatment for rheumatoid arthritis. Am J Med Sci 332:39–42PubMedCrossRef
Metadata
Title
Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis
Authors
Soo-Kyung Cho
Il Hwan Oh
Chan Kum Park
Sang-Cheol Bae
Yoon-Kyoung Sung
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1350-4

Other articles of this Issue 4/2012

Rheumatology International 4/2012 Go to the issue

Original Article

The status of serum vitamin D in patients with rheumatoid arthritis and undifferentiated inflammatory arthritis compared with controls

Short Communication

Polyarteritis nodosa presenting with clinical and radiologic features suggestive of polymyositis

Letter to the Editor

Misdiagnosis of Ewing’s sarcoma of the ilium at the pelvis X-ray

Review

T helper cell subsets in arthritis and the benefits of immunomodulation by 1,25(OH)2 vitamin D

Original Article

The prevalences of some rheumatic diseases in western Turkey: Havsa study

Original Article

The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits